Update on the Use of Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction

Publisher： Karger

E-ISSN： 1661-7657|2|3|113-121

ISSN： 1661-7649

Source： Current Urology, Vol.2, Iss.3, 2009-01, pp. : 113-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 90, Iss. 3, 2012-12 ,pp. : 339-347

Karger

Access to resources Recommend Favorite

Risk–benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 4, 2015-04 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction in Patients with Spinal Cord Trauma: Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 98, Iss. 2, 2016-08 ,pp. : 198-204

Karger

Access to resources Recommend Favorite

Surgical Treatment of Erectile Dysfunction

By  

SEXUAL MEDICINE REVIEWS, Vol. 3, Iss. 4, 2015-10 ,pp. : 316-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient Satisfaction with Testosterone Supplementation for the Treatment of Erectile Dysfunction

By Monga M.   Kostelec M.   Kamarei M.  

Archives of Andrology, Vol. 48, Iss. 6, 2002-11 ,pp. : 433-442

Informa Healthcare

Access to resources Recommend Favorite